683 Capital Management’s Eiger BioPharmaceuticals, Inc. EIGR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-29,660
| Closed | -$148K | – | 150 |
|
|
2024
Q1 | $148K | Sell |
29,660
-40,340
| -58% | -$202K | 0.01% | 89 |
|
|
2023
Q4 | $471K | Sell |
70,000
-18,333
| -21% | -$123K | 0.04% | 79 |
|
|
2023
Q3 | $808K | Sell |
88,333
-36,667
| -29% | -$336K | 0.06% | 83 |
|
|
2023
Q2 | $2.64M | Sell |
125,000
-6,667
| -5% | -$141K | 0.19% | 71 |
|
|
2023
Q1 | $3.54M | Buy |
131,667
+27,834
| +27% | +$749K | 0.26% | 78 |
|
|
2022
Q4 | $3.68M | Sell |
103,833
-40,492
| -28% | -$1.43M | 0.31% | 71 |
|
|
2022
Q3 | $32.6M | Buy |
144,325
+15,492
| +12% | +$3.5M | 2.52% | 8 |
|
|
2022
Q2 | $24.4M | Buy |
128,833
+16,333
| +15% | +$3.09M | 1.72% | 15 |
|
|
2022
Q1 | $28M | Buy |
112,500
+2,500
| +2% | +$623K | 1.5% | 10 |
|
|
2021
Q4 | $17.1M | Buy |
110,000
+4,167
| +4% | +$649K | 0.63% | 31 |
|
|
2021
Q3 | $21.2M | Buy |
105,833
+7,500
| +8% | +$1.5M | 0.83% | 27 |
|
|
2021
Q2 | $25.1M | Buy |
98,333
+8,880
| +10% | +$2.27M | 0.87% | 22 |
|
|
2021
Q1 | $23.8M | Hold |
89,453
| – | – | 1.26% | 17 |
|
|
2020
Q4 | $33M | Buy |
89,453
+2,023
| +2% | +$746K | 1.56% | 12 |
|
|
2020
Q3 | $21.4M | Buy |
87,430
+15,535
| +22% | +$3.79M | 1.56% | 12 |
|
|
2020
Q2 | $20.7M | Buy |
71,895
+3,895
| +6% | +$1.12M | 1.66% | 9 |
|
|
2020
Q1 | $13.9M | Buy |
68,000
+6,333
| +10% | +$1.29M | 1.63% | 13 |
|
|
2019
Q4 | $27.6M | Sell |
61,667
-351
| -0.6% | -$157K | 3.15% | 4 |
|
|
2019
Q3 | $19.1M | Buy |
62,018
+834
| +1% | +$256K | 2.12% | 8 |
|
|
2019
Q2 | $19.5M | Buy |
61,184
+7,500
| +14% | +$2.39M | 1.77% | 10 |
|
|
2019
Q1 | $22.5M | Hold |
53,684
| – | – | 2.04% | 8 |
|
|
2018
Q4 | $16.4M | Buy |
53,684
+32,643
| +155% | +$9.95M | 0.99% | 13 |
|
|
2018
Q3 | $7.58M | Buy |
21,041
+11,198
| +114% | +$4.03M | 0.49% | 27 |
|
|
2018
Q2 | $3.6M | Buy |
9,843
+3,333
| +51% | +$1.22M | 0.24% | 50 |
|
|
2018
Q1 | $1.92M | Buy |
+6,510
| New | +$1.92M | 0.17% | 62 |
|